{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:52:47Z","timestamp":1793494367073,"version":"4.5.0"},"reference-count":35,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2010,6]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The use of strong opioids for treatment of noncancer chronic pain has increased. However, strong evidence for sustained pain relief and improved function is lacking. Controversy prevails, whether hormonal changes are induced by long-term treatment with opioids. The purpose of this study was to investigate the occurrence of endocrine dysfunction in chronic pain patients on long-term opioid treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A study group of 39 chronic pain patients treated with strong oral opioids for more than 1 year was compared with a control group of 20 chronic pain patients without opioid treatment. Basic levels of prolactin and function of the hypothalamic-pituitary-thyroid-, hypothalamic-pituitary-adrenal-axis, and hypothalamic-pituitary-growth-hormone - and hypothalamic-pituitary-gonadal-axis were measured. Quality-of-life and side effects were estimated with EORTC-QLQ-C30.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>In the opioid-treated group, the patients had signs of pituitary dysfunction affecting all axes. Significant differences were shown in hypofunction of the hypothalamic-pituitary-gonadal -axis, hyperfunction of the hypothalamic-pituitary-adrenal -axis, and higher prolactin levels in the opioid-treated group, compared with the control group. The degree of pain was rated the same in both groups, but the opioid-treated group reported more side effects and lower quality of life.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Long-term treatment of chronic pain with strong opioids causes side effects that can be attributed to hormonal abnormalities caused by opioid-induced inhibition of hypothalamic-pituitary function. Hormone substitution can be indicated to treat symptoms. Decreasing the opioid dose or stopping the opioid treatment can reverse endocrine dysfunction. This needs to be recognized by all practitioners treating chronic pain patients with opioids.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/ajp.0b013e3181d1059d","type":"journal-article","created":{"date-parts":[[2010,5,14]],"date-time":"2010-05-14T03:41:26Z","timestamp":1273808486000},"page":"374-380","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":121,"title":["Opioid Endocrinopathy: A Clinical Problem in Patients With Chronic Pain and Long-term Oral Opioid Treatment"],"prefix":"10.1097","volume":"26","author":[{"given":"Annica","family":"Rhodin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mats","family":"Stridsberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Torsten","family":"Gordh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-3-20251219","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.ejpain.2005.06.009","article-title":"Survey of chronic pain in Europe: prevalence, impact on daily life, and treatment","volume":"10","author":"Breivik","year":"2006","journal-title":"Eur J Pain"},{"key":"R2-3-20251219","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1155\/2002\/323085","article-title":"Chronic pain in Canada--prevalence, treatment, impact and the role of opioid analgesia","volume":"7","author":"Moulin","year":"2002","journal-title":"Pain Res Manag"},{"key":"R3-3-20251219","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/0304-3959(86)90091-6","article-title":"Chronic use of opioid analgesics in non-malignant pain: report of 38 cases","volume":"25","author":"Portenoy","year":"1986","journal-title":"Pain"},{"key":"R4-3-20251219","doi-asserted-by":"crossref","first-page":"185","DOI":"10.3109\/10401239209149570","article-title":"Chronic non-malignant pain treatment with long term analgesics","volume":"4","author":"Bouckoms","year":"1992","journal-title":"Ann Clin Psychiatry"},{"key":"R5-3-20251219","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.pain.2004.09.019","article-title":"Opioids in chronic non-cancer pain: systematic review of efficacy and safety","volume":"112","author":"Kalso","year":"2004","journal-title":"Pain"},{"key":"R6-3-20251219","doi-asserted-by":"crossref","first-page":"479","DOI":"10.36076\/ppj.2007\/10\/479","article-title":"Opioid analgesia: perspectives on right use and utility","volume":"10","author":"Ballantyne","year":"2007","journal-title":"Pain Physician"},{"key":"R7-3-20251219","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1210\/jcem.85.6.6615","article-title":"Endocrine consequences of long-term intrathecal administration of opioids","volume":"85","author":"Abs","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"R8-3-20251219","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1054\/npep.1999.0793","article-title":"Mu and delta opioid receptor regulation of pro-opiomelanocortin peptide secretion from the rat neurointermediate pituitary in vitro","volume":"34","author":"Carr","year":"2000","journal-title":"Neuropeptides"},{"key":"R9-3-20251219","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1146\/annurev.ph.48.030186.002523","article-title":"Endogenous opioid peptides and hypothalamo-pituitary function","volume":"48","author":"Howlett","year":"1986","journal-title":"Annu Rev Physiol"},{"key":"R10-3-20251219","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1073\/pnas.96.4.1722","article-title":"beta-Endorphin blocks luteinizing hormone-releasing hormone release by inhibiting the nitricoxidergic pathway controlling its release","volume":"96","author":"Faletti","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R11-3-20251219","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1111\/j.1365-2796.2005.01483.x","article-title":"Chronic fentanyl application induces adrenocortical insufficiency","volume":"257","author":"Oltmanns","year":"2005","journal-title":"J Intern Med"},{"key":"R12-3-20251219","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1054\/jpai.2002.126790","article-title":"Hypogonadism in men consuming sustained-action oral opioids","volume":"3","author":"Daniell","year":"2002","journal-title":"J Pain"},{"key":"R13-3-20251219","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.jpain.2007.08.005","article-title":"Opioid endocrinopathy in women consuming prescribed sustained-action opioids for control of nonmalignant pain","volume":"9","author":"Daniell","year":"2008","journal-title":"J Pain"},{"key":"R14-3-20251219","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/S0885-3924(01)00294-9","article-title":"Equianalgesic dose ratios for opioids. a critical review and proposals for long-term dosing","volume":"22","author":"Pereira","year":"2001","journal-title":"J Pain Symptom Manage"},{"key":"R15-3-20251219","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1093\/jnci\/85.5.365","article-title":"The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology","volume":"85","author":"Aaronson","year":"1993","journal-title":"J Natl Cancer Inst"},{"key":"R16-3-20251219","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S1090-3801(03)00044-2","article-title":"Pain questionnaires in the analysis of long lasting (chronic) pain conditions","volume":"7","author":"Wincent","year":"2003","journal-title":"Eur J Pain"},{"key":"R17-3-20251219","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/0885-3924(94)90166-X","article-title":"Altered sexual function and decreased testosterone in patients receiving intraspinal opioids","volume":"9","author":"Paice","year":"1994","journal-title":"J Pain Symptom Manage"},{"key":"R18-3-20251219","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1097\/00002508-200205000-00002","article-title":"Sex hormone suppression by intrathecal opioids: a prospective study","volume":"18","author":"Roberts","year":"2002","journal-title":"Clin J Pain"},{"key":"R19-3-20251219","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/S0885-3924(03)00331-2","article-title":"Hypogonadism and sexual dysfunction in male cancer survivors receiving chronic opioid therapy","volume":"26","author":"Rajagopal","year":"2003","journal-title":"J Pain Symptom Manage"},{"key":"R20-3-20251219","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1300\/J069v24n02_08","article-title":"Methadone maintenance and male sexual dysfunction","volume":"24","author":"Brown","year":"2005","journal-title":"J Addict Dis"},{"key":"R21-3-20251219","first-page":"269","article-title":"Effects of oral treatment with sustained release morphine tablets on hypothalamic-pituitary-adrenal axis","volume":"19","author":"Palm","year":"1997","journal-title":"Methods Find Exp Clin Pharmacol"},{"key":"R22-3-20251219","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1038\/sj.npp.1300156","article-title":"Corticotropin-releasing factor testing reveals a dose-dependent difference in methadone maintained vs control subjects","volume":"28","author":"Schluger","year":"2003","journal-title":"Neuropsychopharmacology"},{"key":"R23-3-20251219","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.pain.2004.12.007","article-title":"Predicting the failure of disc surgery by a hypofunctional HPA axis: evidence from a prospective study on patients undergoing disc surgery","volume":"114","author":"Geiss","year":"2005","journal-title":"Pain"},{"key":"R24-3-20251219","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.ejpain.2007.10.009","article-title":"Pain, disability and coping reflected in the diurnal cortisol variability in patients scheduled for lumbar disc surgery","volume":"12","author":"Johansson","year":"2007","journal-title":"Eur J Pain"},{"key":"R25-3-20251219","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/j.jpain.2006.04.011","article-title":"DHEAS deficiency during consumption of sustained-action prescribed opioids: evidence for opioid-induced inhibition of adrenal androgen production","volume":"7","author":"Daniell","year":"2006","journal-title":"J Pain"},{"key":"R26-3-20251219","doi-asserted-by":"crossref","first-page":"5293","DOI":"10.1210\/jc.2003-030449","article-title":"The value of dehydroepiandrosterone sulfate measurements in the assessment of adrenal function","volume":"88","author":"Nasrallah","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"R27-3-20251219","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/sj.ijir.3901294","article-title":"Women with low libido: correlation of decreased androgen levels with female sexual function index","volume":"17","author":"Turna","year":"2005","journal-title":"Int J Impot Res"},{"key":"R28-3-20251219","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1055\/s-2004-861554","article-title":"Dehydroepiandrosterone replacement therapy","volume":"22","author":"Arlt","year":"2004","journal-title":"Semin Reprod Med"},{"issue":"4","key":"R29-3-20251219","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1016\/S0015-0282(02)02987-4","article-title":"Dehydroepiandrosterone: a springboard hormone for female sexuality","volume":"77","author":"Spark","year":"2002","journal-title":"Fertil Steril"},{"key":"R30-3-20251219","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0306-4530(02)00134-8","article-title":"Musculo-skeletal pain, psychological distress, and hormones during the menopausal transition","volume":"29","author":"Finset","year":"2004","journal-title":"Psychoneuroendocrinology"},{"key":"R31-3-20251219","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/0306-4530(84)90050-7","article-title":"Morphine inhibits cortisol and stimulates prolactin secretion in man","volume":"9","author":"Zis","year":"1984","journal-title":"Psychoneuroendocrinology"},{"key":"R32-3-20251219","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.pain.2006.06.009","article-title":"Critical issues on opioids in chronic non-cancer pain: an epidemiological study","volume":"125","author":"Eriksen","year":"2006","journal-title":"Pain"},{"key":"R33-3-20251219","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1097\/00007632-200301150-00010","article-title":"Clinical characteristics of chronic back pain as a function of gender and oral opioid use","volume":"28","author":"Fillingim","year":"2003","journal-title":"Spine"},{"key":"R34-3-20251219","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.1097\/00007632-199812010-00014","article-title":"Opioid therapy for chronic noncancer back pain. A randomized prospective study","volume":"23","author":"Jamison","year":"1998","journal-title":"Spine"},{"key":"R35-3-20251219","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1212\/01.WNL.0000057720.36503.2C","article-title":"Controlled-release oxycodone for pain in diabetic neuropathy: a randomized controlled trial","volume":"60","author":"Gimbel","year":"2003","journal-title":"Neurology"}],"container-title":["The Clinical Journal of Pain"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00002508-201006000-00003","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T11:00:15Z","timestamp":1766142015000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00002508-201006000-00003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,6]]},"references-count":35,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1097\/ajp.0b013e3181d1059d","relation":{},"ISSN":["0749-8047"],"issn-type":[{"value":"0749-8047","type":"print"}],"subject":[],"published":{"date-parts":[[2010,6]]}}}